Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Doherty

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
The Medical Journal of Australia|January 15, 1996
HTLV-I in Australia and Oceania: long-term resident or recent immigrant?R R Doherty
The Medical Journal of Australia|June 2, 2001
Preventing transmission of HIV from mothers to babies in AustraliaR R Doherty
The Medical Journal of Australia|July 5, 1993
HTLV-I among Northern Territory aboriginesI Bastian, Y Hinuma, R R Doherty
The Medical Journal of Australia|October 19, 1987
Third International Conference on the acquired immunodeficiency syndromeB P Mulhall, R R Doherty, A J Mijch
Lancet (London, England)|March 5, 1988
Severe dapsone syndrome due to weekly maloprimM L Grayson, A P Yung, R R Doherty
Journal of Virological Methods|December 1, 1988
Quantitation of infectious human immunodeficiency virus using a modified plaque forming assayR E Kiernan, D A McPhee, R R Doherty
The Medical Journal of Australia|July 21, 1997
"On-the-spot" vaccinationM J Bartlett, R R Doherty, P D Fullerton, et al.
The Journal of Infectious Diseases|September 1, 1990
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndromeC J Birch, G Tachedjian, R R Doherty, et al.
Clinical and Experimental Immunology|January 1, 1992
Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1S J Bell, D A Cooper, B E Kemp, et al.
Clinical and Experimental Immunology|October 1, 1992
Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI)S J Bell, D A Cooper, B E Kemp, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
The Medical Journal of Australia|January 15, 1996
HTLV-I in Australia and Oceania: long-term resident or recent immigrant?R R Doherty
The Medical Journal of Australia|June 2, 2001
Preventing transmission of HIV from mothers to babies in AustraliaR R Doherty
The Medical Journal of Australia|July 5, 1993
HTLV-I among Northern Territory aboriginesI Bastian, Y Hinuma, R R Doherty
The Medical Journal of Australia|October 19, 1987
Third International Conference on the acquired immunodeficiency syndromeB P Mulhall, R R Doherty, A J Mijch
Lancet (London, England)|March 5, 1988
Severe dapsone syndrome due to weekly maloprimM L Grayson, A P Yung, R R Doherty
Journal of Virological Methods|December 1, 1988
Quantitation of infectious human immunodeficiency virus using a modified plaque forming assayR E Kiernan, D A McPhee, R R Doherty
The Medical Journal of Australia|July 21, 1997
"On-the-spot" vaccinationM J Bartlett, R R Doherty, P D Fullerton, et al.
The Journal of Infectious Diseases|September 1, 1990
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndromeC J Birch, G Tachedjian, R R Doherty, et al.
Clinical and Experimental Immunology|January 1, 1992
Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1S J Bell, D A Cooper, B E Kemp, et al.
Clinical and Experimental Immunology|October 1, 1992
Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI)S J Bell, D A Cooper, B E Kemp, et al.
Pageof 3